Blood Drug Testing

Company expands colorectal cancer detection to London

Summary: GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, announced Thursday (Feb. 19) that it has expanded access to the world's first blood-based test to determine a person's current risk for colorectal cancer, into southwestern Ontario, with London as the hub of the expansion.

Image Dimensions: 120 x 60